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Practice points
• Functional decline is one of the main outcomes in older adult’s health and especially in dementia.
• Targeting functional decline as an important outcome could contribute to a better and more holistic approach to
dementia.
• This is the first work that examined the association of hippocampal subfield volume (HSv) and functional decline
in dementia with Lewy bodies (DLB).
• Our results suggest differential volume patterns in Alzheimer’s disease compared with DLB, in line with previous
studies, lower HSv were found in the Alzheimer’s disease group, compared with DLB.
• Both structural and functional brain techniques should be considered in the evaluation of functional decline in
dementia.
• According to our results, baseline HSv were not associated with the decline rate in activities of daily living
performance.
• Early functional brain changes (e.g., earlier cholinergic deficits) could be more important than atrophy in people
diagnosed with DLB.
• Activities of daily living performance is influenced by many factors rather than only early hippocampal atrophy.
Background: Hippocampal atrophy is presented in Alzheimer’s disease (AD) and dementia with Lewy bod-
ies (DLB). Cognition, dual-tasks, muscular function, goal-related behaviors and neuropsychiatric symptoms
are linked to hippocampal volumes and may lead to functional decline in activities of daily living. We ex-
amined the association between baseline hippocampal subfield volumes (HSv) in mild AD and DLB, and
functional decline. Materials & methods: 12 HSv were computed from structural magnetic resonance im-
ages using Freesurfer 6.0 segmentation. Functional decline was assessed using the rapid disability rating
scale score. Linear regressions were conducted. Results: In AD, HSv were smaller bilaterally. However, HSv
were not associated with functional decline. Conclusion: Functional decline does not depend on HSv in
mild AD and DLB.
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Hippocampal atrophy is a characteristic feature of Alzheimer’s disease (AD) [1] but it can also occur in dementia
with Lewy bodies (DLB) [2]. However, structural MRI (sMRI) has shown differential atrophy patterns in AD and
DLB, suggesting relative sparing of the hippocampal volume in DLB [3]. By contrast, pathological examinations of
DLB cases have shown a high frequency of concomitant AD pathology [4], and a high burden of alpha-synuclein
accumulations in CA2-3 and the entorhinal cortex [5]. Since several works have considered the hippocampus as
a homogeneous structure, recent sMRI studies examined the hippocampal subfield volumes (HSv) implementing
various automatic segmentation methods [6–8]. In neurodegenerative disorders, HSv atrophy has been reported in
amnestic mild cognitive impairment [9], AD [1], Parkinson disease cognitive decline [10], and DLB [6,11], proposing
the HSv as a potential diagnostic and prognostic marker in dementia.
In addition to its role in memory, the hippocampus is involved in gait control and speed, motor dual-tasks,
stride time, muscular function [12] and neuropsychiatric symptoms [8]. As many of these functions facilitate the
performance of activities of daily living (ADL) and can predict functional decline [13,14], the volumes of specific
HSv might be associated with the functional decline in AD and other neurodegenerative dementias. However, few
studies have explored this association, in particular in DLB. Therefore, the objective of the current study was to
examine the possible association between the functional decline (over a 5 years follow-up), and the baseline volumes
of specific HSv in mild AD and mild DLB patients. We hypothesize that lower volumes at mild AD and mild DLB
diagnosis may be associated with functional decline in dementia.
Materials & methods
The participants were selected from ‘The Dementia Study of Western Norway’ (DemVest), a cohort of patients
with mild dementia recruited from all dementia clinics in Hordaland and Rogaland counties in Norway. The main
inclusion period took place between 2005 and 2007. Exclusion criteria were: absence of dementia, moderate or
severe dementia, delirium, previous bipolar or psychotic disorder, terminal illness, or recently diagnosed major
somatic disease. Details of the design, recruitment, clinical and biomarker procedures are described elsewhere [15].
All participants signed informed consent before inclusion, and the study was approved by the regional ethics
committee and the Norwegian authorities. Patients were followed yearly or until death, and data from the first
5 years are used in this study. We included 119 subjects diagnosed with AD and DLB with available MRI images
at baseline (AD = 84, DLB = 35). Dropouts due to death and loss to follow-up were depicted in Figure 1.
Clinical assessments
Structured medical assessments, relevant information regarding past medical history and medical records were
used to obtain complete and detailed medical background. Comorbidities were recorded for each subject using
the cumulative illness rating scale (CIRS) [16], based on patient and informant reports. Cognition was evaluated
through the mini-mental state examination (MMSE) [17] and a battery of cognitive tests [15].
Dementia diagnosis
Diagnosis of dementia was made according to DSM-IV criteria and further classified as AD (according to the
National Institute of Neurological and Communicative Disorders, Stroke-Alzheimer’s Disease and Related Disorders
Association) [18], or DLB (according to the International consensus criteria) [19]. Mild dementia was defined as
an MMSE score of at least 20 or a clinical dementia rating scale global score = 1 [20]. Four clinical specialists
independently applied diagnostic criteria verifying diagnosis regularly. In cases of incomplete criteria fulfilling, the
final diagnosis was made through consensus. However, a high congruency between the clinical, imaging and the
neuropathological diagnosis was achieved, since 26 DLB patients have dopamine transporter scans, and pathological
diagnosis was available for 20 DLB and 36 AD patients [15,21].
Functional decline: dependent variable
Functional decline, based on ADL was evaluated yearly through the rapid disability rating scale – 2 [16,22]. For our
analysis, we computed an average score including the following items: eating, making simple food, cooking dinner
and adhere to a diet, mobilization – with or without aids, daily personal care, bathing/showering, dressing (and
finding clothes), toilet usage, use of the phone, buying food and other necessary items, handling money and paying
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bills, having a financial overview plan ahead, to write tax returns and taking medications as prescribed. Each item
was scored on a Likert scale (alone = 1, with some help = 2, with substantial help = 3, and cannot perform = 4). ADL
score was obtained using the average score of these 13 items. To determine the decline in function, we calculated
the delta of ADL scores based on the difference between the baseline and the last registered measure of the ADL
score (i.e., up to year 5 or before dead).
sMRI dataset & subfields segmentation
Baseline sMRIs were acquired in three 1.5-T scanners using these acquisition protocols for T1-weighted sequences:
Stavanger: Philips Intera, repetition time (TR) 10.0, echo time (TE) 4.6 ms, tip angle 30◦, 2-mm slice thickness
with a 1-mm gap, number of excitations (NEX) 2, matrix 256 × 256, and a nominal spatial voxel resolution of
1 × 1 × 1.28 mm. Haugesund: Philips Intera, TR 20.0, TE of 4.6 ms, flip angle of 30◦, 1 mm slice thickness
with no gap, NEX 1, matrix 256 × 256 and a voxel size of 1 × 1 × 1.46 mm. Bergen: 1.5 T General Electric
Signa Excite, TR 8.2, TE 3.1 ms, tip angle 7◦, 1-mm slice thickness with no gap, NEX 1, matrix 256 × 256
and voxel resolution of 1 × 1 × 1.33 mm. The sMRIs were acquired in coronal planes in the three centers
(i.e., Stavanger, Bergen and Haugesund). sMRI data with artifacts on visual inspection were excluded (n = 30;
AD = 29; DLB = 1), please see Appendix Table A1 for details about the excluded participants. We applied
a standardized pre processing method for harmonizing multiple collections of sMRI, consisted of movement
correction, non brain tissues erasing, automated calculation of Talairach transformation, intensity normalization,
subcortical white and gray matter segmentation, cortex boundary tessellation, fully automatic topology correction,
and surface deformation to determine CSF/gray matter and gray/white matter boundaries. Following previously
published methods to extract HSv [23], the FreeSurfer 6.0 automated pipeline for hippocampal segmentation was
implemented. HSv segmentation was carried out using a Bayesian method and an ex-vivo MRI atlas algorithm
of the hippocampal formations in ultra-high-resolution (∼0.1 mm isotropic) [24]. Twelve subfields were obtained:
parasubiculum, presubiculum, subiculum, cornu ammonis 1 (CA1), CA2–3, CA4, granule cells in dentate gyrus
(GC-DG), hippocampal-amygdaloid transition area, fimbria, molecular layer, hippocampal fissure and hippocampal
tail as shown in Figure 2. All HSv were rescaled multiplying their values by 1000. Visual inspection of all HSv was
conducted by two researchers blinded to diagnosis for accuracy verification. Total intracranial volumes were also
estimated using FreeSurfer 6.0.
Statistical analysis
Statistical analyses were performed using STATA version 15.0. The statistical significance level of 0.05 was consid-
ered. Frequencies and percentages for nominal variables and mean and standard deviations for continuous variables
were estimated. Group differences in clinical characteristics were evaluated on bivariate analysis using one tail
chi-square test and two tails t-test and Mann–Whitney U. To compare HSv between groups, we controlled for age,
gender and total intracranial volume using ANCOVA followed by posthoc pairwise Tukey’s tests. The influence
of HSv on the functional decline (ADL) was examined through linear regressions. Our linear regression models
were adjusted for age, gender, place where scan had been acquired, neuropsychiatric symptoms, the time between
baseline and last ADL evaluation, and MMSE and CIRS at baseline.
Results
The baseline characteristics of the AD and DLB groups are summarized in Table 1. Age, MMSE and ADL scores
did not differ significantly between AD and DLB, but AD presented fewer comorbidities (CIRS) and had more
women. The DLB group showed a trend to more decline in ADL (see Supplementary Figure A1). The baseline
sMRI volumes are reported in Table 2. The DLB group exhibited statistically significant greater HSv compared
with AD patients. Adjusted ANCOVA maintained the results besides right lower CA2-3 volumes in AD reached a
significance level (p = 0.03).
Tables 3 & 4 show adjusted and unadjusted linear regression models for the right and left HSv in AD and DLB,
respectively. In the adjusted models, we did not find significant associations between change in ADL scores over
follow-up and HSv.
Discussion
To the best of our knowledge, this is the first work that examined the association of HSv and functional decline
in dementia. Our results suggest differential volume patterns in AD compared with DLB, in line with previous
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Table 1. Sample baseline characteristics in mild Alzheimer’s disease and DLB groups.
AD (n = 55) DLB (n = 34) p-value
Age (SD) 74.91 (∓ 0.98) 76.29 (∓ 1.20) 0.3796
Gender <0.0001†
– Woman (%) 41 (74.55) 12 (35.29) -
– Men (%) 14 (25.45) 22 (64.71) -
MMSE score (SD) 23.62 (∓ 0.33) 23.53 (∓ 0.50) 0.8825
CIRS (SD) 5.4 (∓ 0.27) 6.59 (∓ 0.50) 0.0348
ADL score (SD) 1.56 (∓ 0.08) 1.81 (∓ 0.12) 0.0882
†Chi-square test (p-value).
p-values  0.05 are printed in bold.
AD: Alzheimer’s disease; ADL: Activities of daily living; CIRS: Cumulative illness rating scale; DLB: Dementia with Lewy bodies; MMSE: Mini-mental state examination; SD: Standard
deviation.
Table 2. Baseline MRI Hippocampal volumes in mild Alzheimer’s disease and DLB groups.
Hippocampal subfield volumes (Baseline) AD (n = 55) DLB (n = 34) p-value Adjusted
p-value†
Left hemisphere. mean (S.D.)
Hippocampal tail 0.36 (∓0.07) 0.41 (∓ 0.10) 0.0063 0.0019
Subiculum 0.30 (∓ 0.07) 0.35 (∓ 0.08) 0.0039 0.0022
CA1 0.46 (∓ 0.11) 0.53 (∓ 0.12) 0.0102 0.0044
Hippocampal fissure 0.15 (∓ 0.04) 0.16 (∓ 0.04) 0.2184 0.2037
Presubiculum 0.23 (∓ 0.06) 0.27 (∓ 0.06) 0.0057 0.0028
Parasubiculum 0.05 (∓ 0.02) 0.06 (∓ 0.02) 0.0056 0.0023
Molecular Layer 0.39 (∓ 0.09) 0.45 (∓ 0.10) 0.0051 0.0021
GC-DG 0.20 (∓ 0.05) 0.23 (∓ 0.05) 0.0102 0.0055
CA2-3 0.14 (∓ 0.04) 0.16 (∓ 0.04) 0.0355 0.0213
CA4 0.17 (∓ 0.04) 0.20 (∓ 0.05) 0.0114 0.0062
Fimbria 0.04 (∓ 0.02) 0.05 (∓ 0.02) 0.0068 0.0047
HATA 0.04 (∓ 0.01) 0.05 (∓ 0.01) 0.0010 0.0003
Right hemisphere. mean (S.D.)
Hippocampal tail 0.39 (∓ 0.07) 0.45 (∓ 0.10) 0.0033 0.0003
Subiculum 0.31 (∓ 0.07) 0.35 (∓ 0.08) 0.0134 0.0053
CA1 0.51 (∓ 0.11) 0.56 (∓ 0.12) 0.0418 0.0190
Hippocampal fissure 0.17 (∓ 0.04) 0.18 (∓ 0.005) 0.3306 0.2954
Presubiculum 0.22 (∓ 0.05) 0.26 (∓ 0.06) 0.0046 0.0010
Parasubiculum 0.05 (∓ 0.02) 0.06 (∓ 0.02) 0.0916 0.0772
Molecular layer 0.42 (∓ 0.08) 0.47 (∓ 0.10) 0.0146 0.0048
GC-DG 0.22 (∓ 0.04) 0.25 (∓ 0.06) 0.0304 0.0126
CA2-3 0.17 (∓ 0.04) 0.18 8 (∓ 0.05) 0.0596 0.0335
CA4 0.20 (∓ 0.04) 0.22 8 (∓ 0.05) 0.0422 0.0204
Fimbria 0.04 (∓ 0.02) 0.06 (∓ 0.03) 0.0240 0.0086
HATA 0.04 (∓ 0.01) 0.05 (∓ 0.01) 0.0034 0.0010
†ANCOVA (df = 1) controlling for age, sex, intracranial volume with post-hoc Tukey’s pairwise test.
p-values  0.05 are printed in bold.
AD: Alzheimer’s disease; CA: Cornu ammonis; DLB: Dementia with Lewy bodies; GC-DG: Granule cells in dentate gyrus; HATA: Hippocampal–amygdaloid transition area; SD: Standard
deviation.
studies, lower HSv were found in the AD group, compared with DLB [1,6]. On the other hand, none of the studied
HSv at diagnosis of mild AD or DLB were associated with the functional decline.
In dementia, functional decline is one of the main outcomes for patients and clinicians [25]. Even if cognitive
impairments influence functional decline [14], other non cognitive factors such as depression, fecal and urinary
incontinence, frequency of exercise practicing have been taken into consideration as drivers of reduced ADL
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Other causes of dementia
n = 26
Initial sample n = 22
AD: 111; DLB: 85; OD: 26
n = 196
(AD: 111; DLB: 85)
Available MRI n = 119
(AD: 84; DLB: 35)
Year 1 n = 89
(AD: 55; DLB: 34)
Year 2 n = 82
(AD: 49; DLB: 33)
Year 3 n = 73
(AD: 45; DLB: 28)
Year 4 n = 58
(AD: 38; DLB: 20)
Year 5 n = 33
(AD: 24; DLB: 9)
No MRI n = 77
(AD: 27; DLB: 50)
Excluded MRI n = 30
(AD: 29; DLB: 1)
Dropout rate n = 0
Dropout rate n = 7
Deaths = 6; Loss FU = 1
Dropout rate n = 9
Deaths = 8; Loss FU = 1
Dropout rate n = 15
Deaths = 12; Loss FU = 3
Dropout rate n = 25
Deaths = 10; Loss FU = 15
Figure 1. Sample selection and dropout rates.
AD: Alzheimer’s disease; DLB: Dementia with Lewy bodies; Loss FU: Loss to follow-up; OD: Other causes of dementia.
performance [26]. Besides, environmental, physical and sensory impairments may affect some of the basic ADL but
not all activities [27]. Thus, the functional decline might not be explained only by atrophy of HSv in mild-stage of
AD or DLB, supporting that impairments in ADL may result from several factors (i.e., functional brain changes,
polypharmacy, malnutrition, sarcopenia, mobility and social issues, and other geriatric syndromes) [28,29]. Different
scales of ADL should be implemented to elucidate if HSv can be related to overall functional decline rather than
specific dysfunction in motor and cognitive tasks.
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Figure 2. Hippocampal subfields segmentation in a coronal view.
CA: Cornu ammonis; GC-DG: Granule cells in dentate gyrus; HATA: Hippocampal–amygdaloid transition area.
In dementia and aging process, HSv have been linked to certain motor and cognitive deficits. In healthy
older adults, volumes of the presubiculum have been related to lower gait speed [30]. Also, the presubiculum and
parasubiculum have been associated with the spatiotemporal framework and context, as part of the retrosplenial
integration/movement pathway [31]. Dentate gyrus has exhibited strong relations with spatial navigation and pattern
separation, and memory tasks have been mainly related to CA1, CA3 and dentate gyrus [32]. Similarly, in AD patients,
volume loss in CA1 and subiculum has been associated with AD pathology, cognitive deterioration, duration and
severity of dementia [33]. Bilateral damages in the CA and subiculum regions were reported in AD, but not in
DLB. By contrast, DLB patients have exhibited predominant atrophy in extrahippocampal structures correlated
to visuospatial abilities (i.e., perirhinal cortex and parahippocampus) particularly in the right hemisphere [34].
However, based on our results, we can suggest that impairments in overall ADL might not be the result of volume
loss in one structure with multiple functions (i.e., the hippocampus), but maybe some of these activities may be
related with hippocampal volumes. Therefore, further characterizations of HSv and extra hippocampal regions
using specific-hippocampal sMRI protocols and various segmentation methods should be conducted since volume
sparing in the medial temporal lobe is a supportive criterion for DLB diagnosis [19], but only a minority of DLB
cases have pure forms of alpha-synuclein aggregation while overlapping of synucleinopathy and AD pathology (tau
and amyloid-β 42) is widely presented [4], and may potentially lead to a reduction of HSv [35].
In addition to structural atrophy, functional brain changes should be considered in the study of ADL decline.
In line with this, early functional brain changes (e.g., earlier cholinergic deficits) could be more important than
atrophy in people diagnosed with DLB [3]. Thus, impairments in sensorimotor, occipital visual, frontoparietal and
default mode networks have earlier been described [36,37] in DLB patients. All of these could be explained by an
early synaptic dysfunction model which could explain clinical features and trigger later specific atrophy patterns in
LBD [38]. This hypothesis should be considered for future research.
There are several strengths and limitations to our work. We included a long follow-up, an innovative approach for
segmentation, aiming at patient, and clinician important outcomes such as ADL. By contrast, potential selection
bias is given by recruitment in dementia referral clinics. DLB group has a high dropout rate probably due to worse
prognosis that could affect follow-up adherence. Also, no control group was available for contrasting our results.
Further, the automatic segmentation method has some limitations [7,39]. The method has been robustly validated
against the gold standard of manual segmentation but the atlas used in FreeSurfer 6.0 segmentation has not been
validated yet [40]. The use of Freesurfer 6.0 on T1-weighted MRI data also has limitations: the HSv were extracted
from images acquired with a non-specific protocol for the hippocampus, and the resolution of images does not
provide sufficient information to visualize inner structures such as the stratum radiatum lacunosum-moleculare,
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Table 3. Linear regression for assessing the hippocampal subfield volumes effect on the functional decline (determined




Left hemisphere Right hemisphere
Hippocampal subfield volume Estimation SE p-value r2 Estimation SE p-value r2
Hippocampal tail 17.68 1821.1 0.9923 0.00% -442.54 2194.6 0.841 0.08%
Subiculum -1535.67 2045.9 0.4564 1.11% -4185.94 2051.4 0.0466 7.69%
CA1 -464.06 1354.6 0.7333 0.23% -1968.28 1345 0.1496 4.11%
Hippocampal fissure 556.66 3363.4 0.8692 0.05% -2351.8 3334.4 0.4839 0.99%
Presubiculum -925.53 2638.9 0.7273 0.25% -2126.64 3218.9 0.5119 0.87%
Parasubiculum -1682.52 9374.8 0.8583 0.06% -7213.62 9432.7 0.448 1.16%
Molecular layer -798.28 1688.8 0.6385 0.44% -2570.09 1699.7 0.1368 4.37%
GC-DG -1315.23 3222.1 0.6849 0.33% -5179.31 3294.6 0.1222 4.71%
CA2-3 -219.06 4300.9 0.9596 0.01% -5673.39 4058.5 0.1683 3.76%
CA4 -980.18 3636 0.7886 0.15% -5046.23 3720.2 0.1811 3.55%
Fimbria -5916.32 8494.9 0.4894 0.96% -5419.63 8109.7 0.507 0.89%
HATA -8542.31 12,946 0.5124 0.86% -33,189.84 11,703.2 0.0066 13.86%
Adjusted model
Left hemisphere Right hemisphere
Hippocampal subfield volume Estimation SE p-value r2 Estimation SE p-value r2
Hippocampal tail -521.82 1734 0.7649 40.40% 138.95 1909.4 0.9423 40.28%
Subiculum -1543.87 1981.8 0.4402 41.10% -2401.91 2052.5 0.2483 42.12%
CA1 -226.82 1198.5 0.8508 40.32% -226.82 1198.5 0.8508 40.32%
Hippocampal fissure 584.72 3659.7 0.8738 40.31% 10.63 3702.9 0.9977 40.27%
Presubiculum 522.66 2474.9 0.8337 40.34% 1298.14 3098.3 0.6773 40.52%
Parasubiculum 3244.12 8497.5 0.7045 40.48% 4857.55 8356.6 0.5641 40.74%
Molecular Layer -798.28 1688.8 0.6385 0.44% -798.28 1688.8 0.6385 0.44%
GC-DG -1538.09 2997.9 0.6105 40.64% -3644.11 3099.1 0.2461 42.13%
CA2-3 -865.92 4031.6 0.8309 40.34% -5404.07 3895.1 0.1725 42.83%
CA4 -1372.56 3482.6 0.6954 40.49% -3902.21 3554 0.2783 41.90%
Fimbria -9564.96 7451.7 0.2062 42.48% -5812.19 7147.1 0.4206 41.18%
HATA -1225.42 12,988.8 0.9253 40.29% -13,662.09 12,416.1 0.2773 41.91%
p  0.05 are printed in bold.
In the adjusted model Age, Sex, MMSE, CIRS, Site, NPI, and time between first and last measurements were included.
AD: Alzheimer’s disease; ADL: Activities of daily living; CA: Cornu ammonis; CIRS: Cumulative illness rating scale; GC-DG: Granule cells in dentate Gyrus; HATA: Hippocampal–amygdaloid
transition area; MMSE: Mini-mental state examination; SE: Standard error.
which makes up a large portion of the borders between CA and the DG, and between the subiculum and DG. This
makes that the subfield measures generated may not represent the cytoarchitectonic different subfields. Estimated
volumes for internal subfields such as GC-DG, CA4, and Molecular layer must be interpreted with caution.
Nevertheless, FreeSurfer 6.0 provides useful information in other structures such as the fimbria and hippocampal
tail, reliable at 1 mm T1 data [24]. It is crucial to note that these are widely known problems in HSv segmentations
using sMRI, and even when subregions are manually segmented remain showing high variability [10]. Therefore,
automatic segmentation allows reproducible methods, obtaining similar volumes using the subfield algorithm when
compared with manual tracing that can be biased, labor-intensive, and time-consuming [7,10]. The inclusion of
different scanners in our study may lead to inconsistent results, to account for that we added the center as a
covariate in our statistical models. Previous estimations from different scanners using Freesurfer 6.0 have shown
reliable results [41].
future science group 10.2217/nmt-2020-0039
Short Communication Borda, Jaramillo-Jimenez, Tovar-Rios et al.
Table 4. Linear regression for assessing the hippocampal subfield volumes effect on the functional decline (determined
by the difference between first and last available activities of daily living score) in DLB patients during follow-up.
DLB
Unadjusted model
Left hemisphere Right hemisphere
Hippocampal subfield volume Estimation SE p-value r2 Estimation SE p-value r2
Hippocampal tail -3572.11 6870.6 0.6069 0.89% 41.28 7504.2 0.9956 0.00%
Subiculum -7084.65 9831.7 0.4767 1.70% 5810.64 10,240.7 0.5747 1.06%
CA1 -2397.39 6332.9 0.7077 0.48% 1704.01 6628.2 0.7989 0.22%
Hippocampal fissure -18,577.98 15,804.6 0.249 4.40% 9033.21 14,267.9 0.5315 1.32%
Presubiculum -9359.85 11,419.3 0.4189 2.19% 5659.79 11,945.3 0.6391 0.74%
Parasubiculum -40,687.44 38,772.6 0.3024 3.54% 48,287.39 47,045.1 0.3129 3.39%
Molecular layer -3245.06 7909 0.6845 0.56% 6088.18 7861 0.4447 1.96%
GC-DG -4136.16 13,725 0.7652 0.30% 10,105.57 13,489.2 0.4596 1.84%
CA2-3 5.61 17,443.4 0.9997 0.00% 11,014.44 16,481.4 0.5091 1.47%
CA4 -5604.78 15,639.4 0.7226 0.43% 8873.47 14,913.3 0.5563 1.17%
Fimbria 49,010.13 34,488.6 0.1656 6.31% 42,181.35 25,385.2 0.107 8.43%
HATA -15,863.77 49,283.7 0.7498 0.34% 25,248.39 50,768.2 0.6226 0.82%
Adjusted model
Left hemisphere Right hemisphere
Hippocampal subfield volume Estimation SE p-value r2 Estimation SE p-value r2
Hippocampal tail -262.67 1610.1 0.8719 63.36% -442.54 2194.6 0.841 63.84%
Subiculum -11.38 2394.7 0.9963 63.32% 1280.59 2381.9 0.5962 63.79%
CA1 -759.27 1668.5 0.6535 63.66% -453.05 1511.7 0.7672 63.46%
Hippocampal fissure 2176.71 3710.5 0.5634 63.88% 2922.04 3001 0.3408 64.83%
Presubiculum -1579.71 2845.8 0.5844 63.82% -444.53 2908.8 0.8799 63.35%
Parasubiculum -6741.21 9183.9 0.4707 64.19% 669.03 11061.3 0.9523 63.32%
Molecular layer -798.28 1688.8 0.6385 0.44% 53.85 1829.4 0.9768 63.32%
GC-DG -43.67 3325.5 0.9896 63.32% 485.72 3007.3 0.8732 63.36%
CA2-3 972.92 4038.3 0.8118 63.41% 1656.88 3642.2 0.6536 63.66%
CA4 335.03 3732.1 0.9293 63.33% 623.93 3287.1 0.8512 63.38%
Fimbria 6730.62 10,863.4 0.5419 63.94% 6813.99 6146.1 0.2795 65.26%
HATA 4301.92 12,218.8 0.7281 63.52% 2259.64 11,651 0.848 63.38%
In the adjusted model Age, Sex, MMSE, CIRS, Site, NPI, and time between first and last measurements were included.
ADL: Activities of daily living; CIRS: Cumulative illness rating scale; DLB: Dementia with Lewy bodies; HATA: Hippocampal–amygdaloid transition area; MMSE: Mini-mental state exami-
nation; SE: Standard error.
Conclusion
We conclude that in mild stages of AD or DLB, the HSv were not associated with the decline rate in ADL
performance. The overall ADL scores might not be related to subfield volume loss, but individual ADL analysis
may elucidate the contribution of HSv in functional decline. Both structural and functional brain techniques
should be considered in the evaluation of functional decline in dementia. Aside from the fact that the hippocampus
has several functions, other factors (i.e., physical, environmental and affective) may influence ADL performance
rather than only early hippocampal atrophy.
Supplementary data
To view the supplementary data that accompany this paper please visit the journal website at:
www.futuremedicine.com/doi/suppl/10.2217/nmt-2020-0039
Author contributions
A Jaramillo-Jimenez: conception of work, formal analysis, methodology, visualization, writing, reviewing, editing and approval. MG
Borda: conception of work, methodology, visualization, writing, reviewing, editing and approval. E Garcia-Cifuentes: preparation
of the initial draft, writing, reviewing and approval. AO Vik-Mo: methodology, visualization, writing, reviewing, editing and ap-
10.2217/nmt-2020-0039 Neurodegener. Dis. Manag. (Epub ahead of print) future science group
Hippocampal subfield volume & functional decline Short Communication
proval. V Aarsland: preparation of the initial draft, writing, reviewing, editing and approval. DA Tovar-Rios: formal analysis, writing,
reviewing, editing and approval. D Ferreira: methodology, visualization, writing, reviewing, editing, supervision and approval. D
Aarsland: methodology, visualization, writing, reviewing, editing, supervision and approval. K Oppedal: methodology, visualization,
writing, reviewing, editing, supervision and approval.
Acknowledgments
We want to thank all the participants, researchers and technical staff that have made the DemVest study possible. The views
expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
Financial & competing interests disclosure
This paper represents independent research supported by the Norwegian government, through hospital owner Helse Vest (Western
Norway Regional Health Authority). Also, funded by the National Institute for Health Research (NIHR) Biomedical Research Centre
at South London and Maudsley NHS Foundation Trust and King’s College London. The authors have no other relevant affiliations
or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or
materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Ethical conduct of research
This study was approved by the regional ethics committee (approval code: 2010/633) and the Norwegian authorities for the
collection of medical data. All data were handled and kept under national health and data privacy protocols. All participants
signed an informed consent form before inclusion in the study. The research was conducted ethically following the World Medical
Association Declaration of Helsinki.
References
Papers of special note have been highlighted as: •• of considerable interest
1. Mueller SG, Schuff N, Yaffe K, Madison C, Miller B, Weiner MW. Hippocampal atrophy patterns in mild cognitive impairment and
Alzheimer’s disease. Hum. Brain Mapp. 31(9), 1339–1347 (2010).
2. Mak E, Su L, Williams GB et al. Differential atrophy of hippocampal subfields: a comparative study of dementia with lewy bodies and
Alzheimer disease. Am. J. Geriatr. Psychiatry 24(2), 136–143 (2016).
3. Oppedal K, Ferreira D, Cavallin L et al. A signature pattern of cortical atrophy in dementia with Lewy bodies: a study on 333 patients
from the European DLB consortium. Alzheimers Dement. 15(3), 400–409 (2019).
•• Dementia with Lewy bodies (DLB) of DemVest cohort had higher scores on all the three atrophy scales than normal controls but
had less medial temporal lobe atrophy than those with Alzheimer’s disease. The most common pattern of atrophy of DLB was
hippocampal-sparing.
4. Irwin DJ, Hurtig HI. The contribution of tau, amyloid-beta and alpha-synuclein pathology to dementia in Lewy body disorders. J.
Alzheimer’s Dis. Parkinsonism 8(4), 444 (2018).
5. Adamowicz DH, Roy S, Salmon DP et al. Hippocampal α-synuclein in dementia with lewy bodies contributes to memory impairment
and is consistent with spread of pathology. J. Neurosci. 37(7), 1675–1684 (2017).
6. Mak E, Gabel S, Su L et al. Multi-modal MRI investigation of volumetric and microstructural changes in the hippocampus and its
subfields in mild cognitive impairment, Alzheimer’s disease, and dementia with Lewy bodies. Int. Psychogeriatrics 29(4), 545–555 (2017).
7. Schmidt MF, Storrs JM, Freeman KB et al. A comparison of manual tracing and FreeSurfer for estimating hippocampal volume over the
adult lifespan. Hum. Brain Mapp. 39(6), 2500–2513 (2018).
8. de Schipper LJ, Hafkemeijer A, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ. Regional structural hippocampal
differences between dementia with lewy bodies and Parkinson’s disease. J. Parkinsons. Dis. 9(4), 775–783 (2019).
9. Yassa MA, Stark SM, Bakker A, Albert MS, Gallagher M, Stark CEL. High-resolution structural and functional MRI of hippocampal
CA3 and dentate gyrus in patients with amnestic Mild Cognitive Impairment. Neuroimage 51(3), 1242–1252 (2010).
10. Foo H, Mak E, Chander RJ et al. Associations of hippocampal subfields in the progression of cognitive decline related to Parkinson’s
disease. NeuroImage Clin. 14, 37–42 (2016).
11. Chow N, Aarsland D, Honarpisheh H et al. Comparing hippocampal atrophy in Alzheimer’s dementia and dementia with lewy bodies.
Dement. Geriatr. Cogn. Disord. 34(1), 44–50 (2012).
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